These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2035 related items for PubMed ID: 24630923

  • 1. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM, Mehta AM, Aalbers AG, van Driel WJ, Boot H, Verwaal VJ.
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [Abstract] [Full Text] [Related]

  • 2. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
    Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.
    Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
    [Abstract] [Full Text] [Related]

  • 3. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [Abstract] [Full Text] [Related]

  • 4. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH, Graf W, Nygren P, Mahteme H.
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [Abstract] [Full Text] [Related]

  • 5. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [Abstract] [Full Text] [Related]

  • 6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
    Teo MC, Tan GH, Tham CK, Lim C, Soo KC.
    Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
    [Abstract] [Full Text] [Related]

  • 7. Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chia CS, Tan WJ, Wong JF, Tan GH, Lim C, Wang W, Sin EI, Tham CK, Soo KC, Teo MC.
    Eur J Surg Oncol; 2014 Aug; 40(8):909-16. PubMed ID: 24768445
    [Abstract] [Full Text] [Related]

  • 8. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
    Bignell MB, Mehta AM, Alves S, Chandrakumaran K, Dayal SP, Mohamed F, Cecil TD, Moran BJ.
    Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
    [Abstract] [Full Text] [Related]

  • 9. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin.
    Evers DJ, Verwaal VJ.
    Br J Surg; 2011 Feb; 98(2):287-92. PubMed ID: 21046680
    [Abstract] [Full Text] [Related]

  • 10. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
    Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J.
    Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no?
    Williams BH, Alzahrani NA, Chan DL, Chua TC, Morris DL.
    Eur J Surg Oncol; 2014 Aug; 40(8):943-9. PubMed ID: 24378009
    [Abstract] [Full Text] [Related]

  • 14. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ, van Oudheusden TR, de Hingh IH, Nienhuijs SW, Boerma D, Wiezer MJ, van Ramshorst B.
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [Abstract] [Full Text] [Related]

  • 15. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
    Cascales Campos P, Gil J, Parrilla P.
    Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
    [Abstract] [Full Text] [Related]

  • 16. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
    Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.
    J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
    [Abstract] [Full Text] [Related]

  • 17. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [Abstract] [Full Text] [Related]

  • 18. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M, Vaira M, Marsanic P, Mellano A, Borsano A, Cinquegrana A, Sottile A, De Simone M.
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [Abstract] [Full Text] [Related]

  • 19. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM.
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [Abstract] [Full Text] [Related]

  • 20. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.
    Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Morice P, Pomel C, Pocard M, Guyon F, Porcheron J, Glehen O, FROGHI (FRench Oncologic and Gynecologic HIPEC) Group.
    Eur J Surg Oncol; 2013 Dec; 39(12):1435-43. PubMed ID: 24209430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.